C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402

FDA recall notice · announced April 26, 2023 · Pharmacy Plus, Inc. Dba Vital Care Compounder

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402

Reason for recall

Lack of assurance of sterility.

Notes

Distribution: MS only
Lot/code information: Lot #: 73810, Exp. Date 5/1/2023
Quantity: 45 vials
Status: Ongoing
Products in this recall event:
- C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402 (D-0538-2023)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.